High Risk Cardiovascular Disease Patients
Conditions
Keywords
cardiovascular disease, metabolic disease, high risk, prospective cohort
Brief summary
Set the prospective cohort (CMERC-HI) to study the known and novel etiologies and related factors for predicting clinical outcomes in Korean patients with high risk cardiovascular disease.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* high risk hypertension patients a. eGFR \> 60 with one of target organ damages b. eGFR \<= 60 * diabetes mellitus with microalbumin ration (AC ratio \>= 30mg/g) * anuric ESRD patients on dialysis * the relatives of acute myocardial infarction patients under 55 years old (men)/ 65 years old (women) * atherosclerotic cardiovascular disease (abdominal aorta diameter ≥3 cm or ankle-brachial index \<0.9, or carotid plaque or carotid intima-media thickness ≥0.9 mm, or asymptomatic old cerebrovascular accident, or \>30% stenosis in at least one major coronary artery) * rheumatoid arthritis patients aged \> 40 years on MTX and steroid therapy * atrial fibrillation patients with CHADS-VASc Score ≥ 1 * kidney transplant recipient at \> 3 months after transplantation
Exclusion criteria
* acute myocardial infarction, acute coronary syndrome patients, symptomatic coronary artery disease or history of these diseases * symptomatic peripheral artery disease, heart failure and history of these diseases * desired life time under 6 months due to non-cardiovascular disease (e.g. cancer, sepsis) * women with pregnancy or on nursing * history of contrast allergy and related side effects * within the first three months after transplantation * acute renal allograft rejection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prognosis of high risk cardiovascular disease | 10 year after recruting | all-cause mortality, cardiovascular mortality, non-cardiovascular mortality new onset of acute myocardial infarction, acute coronary syndrome, heart failure, stroke, peripheral artery disease, hospitalization for revascularization and these disease |
Countries
South Korea